SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,116 | -56.2% | 200 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $9,404 | +12.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $8,392 | +10.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $7,628 | -4.6% | 200 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $8,000 | +33.3% | 200 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $7,000 | -22.2% | 200 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $9,000 | 0.0% | 200 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $9,000 | -18.2% | 200 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $11,000 | -26.7% | 200 | 0.0% | 0.01% | -30.8% |
| Q1 2021 | $15,000 | -11.8% | 200 | 0.0% | 0.01% | -23.5% |
| Q4 2020 | $17,000 | – | 200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
| DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
| Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
| BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
| Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
| TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
| OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |